<DOC>
	<DOCNO>NCT02021851</DOCNO>
	<brief_summary>Postoperative nausea vomiting ( PONV ) common problem general anesthesia . The incidence high 80 percent high-risk patient . Investigators design randomize , double- blind , single-center study compare efficacy combination dexamethasone ondansetron dexamethasone aprepitant undergoing laparoscopic surgery . Seventy American Society Anesthesiologist ( ASA ) physical class I-II , age 18-60 year patient schedule laparoscopic surgery include study . Anesthesia induce propofol , fentanyl , rocuronium , maintain sevoflurane oxygen / air mixture patient . Remifentanil continuously infuse surgery . Patients randomly divide two group . Patients dexamethasone aprepitant group ( group DA , n=35 ) receive 40 mg aprepitant orally 1 2 hour induction anesthesia 2 ml saline intravenous ( iv ) within last 30 minute surgery . Patients dexamethasone ondansetron group ( group DO , n=35 ) receive oral placebo identical aprepitant 1 2 hour induction anesthesia 4 mg ondansetron iv within last 30 minute surgery . All patient receive iv 8 mg dexamethasone induction anesthesia . PONV postoperative opioid consumption assess 24 hour postoperatively . The blindly evaluated primary outcome complete response . The secondary outcome incidence nausea , retch vomiting , need rescue antiemetic opioid consumption within 24 hour surgery . Statistical analysis perform use Mann-Whitney U test , Chi-square test , Fisher 's Exact test . P &lt; 0.05 consider statistically significant.Investigators hypothesize antiemetic efficacy aprepitant dexamethasone combination superior compare ondansetron dexamethasone combination follow laparoscopic surgery .</brief_summary>
	<brief_title>Prevention Nausea Vomiting Patients After Surgery</brief_title>
	<detailed_description />
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Postoperative Nausea Vomiting</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Aprepitant</mesh_term>
	<mesh_term>Fosaprepitant</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>18 Years 60 Years ASA ( American Society Anesthesiologist ) physical status I II Patients undergo laparoscopic gynecologic surgery laparoscopic cholecystectomy Hypersensitivity contraindication study medication , Antiemetic drug steroid use within 24 hour anesthesia , History diabetes mellitus , History motion sickness postoperative nausea vomiting , Pregnancy , Breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Dexamethasone ,</keyword>
	<keyword>Ondansetron</keyword>
	<keyword>Aprepitant</keyword>
	<keyword>PONV</keyword>
	<keyword>Laparoscopic surgery</keyword>
</DOC>